Top Health Care Stocks <\/p>\n
JNJ +0.23% <\/p>\n
PFE +0.13% <\/p>\n
ABT +1.08% <\/p>\n
MRK +0.05% <\/p>\n
AMGN +1.81% <\/p>\n
Health care stocks were mostly higher, with the NYSE Health Care Sector Index climbing about 0.1% and shares of health care companies in the S&P 500 posting a 0.5% gain as a group. <\/p>\n
In company news, BioLineRx Ltd. ( BLRX ) rallied Monday after the early-stage biotech company reported positive data from ongoing Phase IIa testing of its BL-8040 drug candidate in patientxs with acute myeloid leukemia. <\/p>\n
The prospective chemotherapy triggered substantial mobilization of leukemia cancer cells from the bone marrow to peripheral blood in patients, including a median 70% drop in the number of leukemia in a patient's bone marrow while the number of normal progenitor cells was stable after only two days of BL-8040 monotherapy. <\/p>\n
BL-8040 also showed a 350% increase in cell death of leukemia cells in both the bone marrow and in peripheral blood samples during additional testing. There also were no dose-limiting toxicity or serious adverse events during the dose-escalation stage of the trial, the company said. <\/p>\n
<\/p>\n
The rest is here:<\/p>\n
Health Care Sector Update for 12\/08\/2014: BLRX,CBST,MRK,ALR<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Top Health Care Stocks JNJ +0.23% PFE +0.13% ABT +1.08% MRK +0.05% AMGN +1.81% Health care stocks were mostly higher, with the NYSE Health Care Sector Index climbing about 0.1% and shares of health care companies in the S&P 500 posting a 0.5% gain as a group. In company news, BioLineRx Ltd. ( BLRX ) rallied Monday after the early-stage biotech company reported positive data from ongoing Phase IIa testing of its BL-8040 drug candidate in patientxs with acute myeloid leukemia Continue reading